Janet Torres

Title: Janet Torres - Innovator in Therapeutic Compositions

Introduction

Janet Torres is a prominent inventor based in San Francisco, California. She has made significant contributions to the field of therapeutic and diagnostic compositions, particularly targeting toll-like receptors. Her innovative work has the potential to improve conditions related to these receptors, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Janet holds a patent for "Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof." This patent outlines a method for improving a Toll-like receptor (TLR)-related condition. The process involves determining a set of peptide sequences associated with a microorganism-related modulator of a TLR. It also includes selecting a target subset of peptide sequences based on binding parameters, reengineering these sequences, and identifying a peptide for therapeutic use.

Career Highlights

Janet's career is marked by her role at Psomagen, Inc., where she applies her knowledge and skills to develop innovative solutions in the field of biotechnology. Her work has garnered attention for its potential impact on therapeutic applications and diagnostics.

Collaborations

Janet collaborates with notable colleagues, including Zachary Apte and Jessica Richman. These partnerships enhance her research and contribute to the advancement of their shared goals in the field of therapeutic innovations.

Conclusion

Janet Torres is a trailblazer in the realm of therapeutic compositions, with a focus on toll-like receptors. Her patent and collaborative efforts reflect her commitment to improving health outcomes through innovative research.